Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Epidermal growth factor receptor (EGFR) gene amplification and rearrangement are common in gliomas.
• EGFR deletion mutants have been identified in glioma cells.
• Previous characterization of a 190-kDa EGFR mutant with tandem duplication in A-172 cells.

Purpose of the Study:

• To describe a novel 185-kDa tandem duplication mutant (TDM) in KE and A-1235 glioma cells.
• To characterize the functional properties of these EGFR tandem duplication mutants.

Main Methods:

• Analysis of gene structure and transcripts in KE and A-1235 glioma cells.
• Investigation of genomic rearrangements associated with exon duplication.
• Functional assays including autophosphorylation, downregulation, ligand binding, and receptor internalization.

Main Results:

• A novel 185-kDa EGFR tandem duplication mutant (TDM) was identified in KE and A-1235 glioma cells.
• The TDM results from an in-frame duplication of exons 18-25, encoding the tyrosine kinase (TK) and part of the calcium-mediated internalization (CAIN) domains.
• Genomic rearrangement involving introns with homology to recombination signal sequences (RSS) mediates the duplication.
• Both oncogenic TDMs are constitutively autophosphorylated and inefficiently downregulated.
• EGFR.TDM/18-26 shows reduced high-affinity binding, but receptor internalization half-life is not prolonged.

Conclusions:

• The identified EGFR tandem duplication mutants (TDMs) are oncogenic, driven by specific genomic rearrangements.
• Constitutive autophosphorylation and impaired downregulation contribute to the aberrant EGFR signaling in gliomas.
• These findings provide insights into the molecular mechanisms underlying EGFR-driven gliomagenesis.